Cargando…

Correction to: DNMT3A low-expression is correlated to poor prognosis in childhood B-ALL and confers resistance to daunorubicin on leukemic cells

Detalles Bibliográficos
Autores principales:	Li, Weijing, Liu, Shuguang, Wang, Chanjuan, Cui, Lei, Zhao, Xiaoxi, Liu, Wei, Zhang, Ruidong, Li, Zhigang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2023
Materias:	Correction
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10120268/ https://www.ncbi.nlm.nih.gov/pubmed/37085757 http://dx.doi.org/10.1186/s12885-023-10862-x

Ejemplares similares

DNMT3A low-expression is correlated to poor prognosis in childhood B-ALL and confers resistance to daunorubicin on leukemic cells
por: Li, Weijing, et al.
Publicado: (2023)

DNMT3A mutations in Chinese childhood acute myeloid leukemia
por: Li, Weijing, et al.
Publicado: (2017)

Quantitative monitoring of minimal residual disease in childhood acute lymphoblastic leukemia using TEL‐AML1 fusion transcript as a marker
por: Zhao, Xiaoxi, et al.
Publicado: (2019)

Hexokinase II inhibition by 3-bromopyruvate sensitizes myeloid leukemic cells K-562 to anti-leukemic drug, daunorubicin
por: Rai, Yogesh, et al.
Publicado: (2019)

Improved Survival of Leukemic Mice Treated with Sodium Caseinate in Combination with Daunorubicin without Toxicity
por: Aguiñiga-Sánchez, Itzen, et al.
Publicado: (2021)

Reciprocal Interactions of Leukemic Cells with Bone Marrow Stromal Cells Promote Enrichment of Leukemic Stell Cell Compartments in Response to Curcumin and Daunorubicin
por: Mohammadi, Saeed, et al.
Publicado: (2017)

Synergistic antitumoral efficacy of a novel replicative adenovirus SG611-PDCD5 and daunorubicin in human leukemic cells
por: Zhou, Ya-Lan, et al.
Publicado: (2018)

Cytotoxic Effects of Vitamin A in Combination with Vincristine, Daunorubicin and 6‐Thioguanine upon Cells from Lymphoblastic Leukemic Patients
por: Pieters, Rob, et al.
Publicado: (1991)

DNMT3A mutation leads to leukemic extramedullary infiltration mediated by TWIST1
por: Xu, Jie, et al.
Publicado: (2016)

DNMT3A and TET2 in the Pre-Leukemic Phase of Hematopoietic Disorders
por: Sato, Hanae, et al.
Publicado: (2016)

High Expression of BCL11A Predicts Poor Prognosis for Childhood MLL-r ALL
por: Wang, Lu-Lu, et al.
Publicado: (2021)

DNMT3A R882H mutation drives daunorubicin resistance in acute myeloid leukemia via regulating NRF2/NQO1 pathway
por: Chu, Xuan, et al.
Publicado: (2022)

Do AML patients with DNMT3A exon 23 mutations benefit from idarubicin as compared to daunorubicin? A single center experience
por: LaRochelle, Olivier, et al.
Publicado: (2011)

Adipocyte metabolism of the chemotherapy daunorubicin
por: Mittelman, Steven D., et al.
Publicado: (2018)

Optical Genome Mapping for Comprehensive Assessment of Chromosomal Aberrations and Discovery of New Fusion Genes in Pediatric B-Acute Lymphoblastic Leukemia
por: Gao, Huixia, et al.
Publicado: (2022)

Increased plasma membrane traffic in daunorubicin resistant P388 leukaemic cells. Effect of daunorubicin and verapamil.
por: Sehested, M., et al.
Publicado: (1987)

DNMT3b/OCT4 expression confers sorafenib resistance and poor prognosis of hepatocellular carcinoma through IL-6/STAT3 regulation
por: Lai, Ssu-Chuan, et al.
Publicado: (2019)

Liposomal daunorubicin as treatment for Kaposi’s sarcoma
por: Petre, Christin E, et al.
Publicado: (2007)

Interactions of Cisplatin and Daunorubicin at the Chromatin Level
por: Firouzi Niaki, Erfaneh, et al.
Publicado: (2020)

PB1759: RETAINED FUNCTIONAL NORMAL AND/OR PRE-LEUKEMIC HSCS IN THE BONE MARROW ARE ASSOCIATED TO GOOD PROGNOSIS IN DNMT3AMUTNPM1MUT AML PATIENTS
por: Donato, Elisa, et al.
Publicado: (2023)

Effect of microRNA-210 on prognosis and response to chemotherapeutic drugs in pediatric acute lymphoblastic leukemia
por: Mei, Yanyan, et al.
Publicado: (2014)

Correction to: DNMT3b/OCT4 expression confers sorafenib resistance and poor prognosis of hepatocellular carcinoma through IL-6/STAT3 regulation
por: Lai, Ssu-Chuan, et al.
Publicado: (2020)

Synthesis and antitumor efficacy of daunorubicin-loaded magnetic nanoparticles
por: Wang, Jun, et al.
Publicado: (2011)

Spectroscopic, Viscositic and Molecular Modeling Studies on the Interaction of 3′-Azido-Daunorubicin Thiosemicarbazone with DNA
por: Cui, Fengling, et al.
Publicado: (2013)

Risk Factors of Daunorubicine Induced Early Cardiotoxicity in Childhood Acute Lymphoblastic Leukemia: A Retrospective Study
por: Samosir, Sunny Mariana, et al.
Publicado: (2021)

Expression and prognosis analysis of DNMT family in acute myeloid leukemia
por: Zhang, Ting-Juan, et al.
Publicado: (2020)

DNMT3A R882 Mutations Predict a Poor Prognosis in AML: A Meta-Analysis From 4474 Patients
por: Yuan, Xiao-Qing, et al.
Publicado: (2016)

Adenovirus-mediated delivery of the human IFN-γ gene potentiates the cytotoxicity of daunorubicin against leukemic cells through downregulation of the α4β1 integrin/ILK/apoptosis pathway
por: ZHANG, JING, et al.
Publicado: (2014)

Dead or alive? The manipulation of neuronal ensembles and pathways by daunorubicin
por: Bashir, Zafar Iqbal, et al.
Publicado: (2017)

Author Correction: Interactions of Cisplatin and Daunorubicin at the Chromatin Level
por: Firouzi Niaki, Erfaneh, et al.
Publicado: (2020)

A new hypothesis: imatinib affects leukemic stem cells in the same way it affects all other leukemic cells
por: Tomasetti, C
Publicado: (2011)

CAR‐T therapy as a consolidation in remission B‐ALL patients with poor prognosis
por: Yin, Zhichao, et al.
Publicado: (2022)

Combination of bortezomib and daunorubicin in the induction of apoptosis in T-cell acute lymphoblastic leukemia
por: Du, Xin, et al.
Publicado: (2017)

DNMT1, DNMT3A and DNMT3B Polymorphisms Associated With Gastric Cancer Risk: A Systematic Review and Meta-analysis
por: Li, Hongjia, et al.
Publicado: (2016)

MiR-15a-5p Confers Chemoresistance in Acute Myeloid Leukemia by Inhibiting Autophagy Induced by Daunorubicin
por: Bollaert, Emeline, et al.
Publicado: (2021)

CPX-351 (cytarabine and daunorubicin) Liposome for Injection Versus Conventional Cytarabine Plus Daunorubicin in Older Patients With Newly Diagnosed Secondary Acute Myeloid Leukemia
por: Lancet, Jeffrey E., et al.
Publicado: (2018)

Daunorubicin-60 versus daunorubicin-90 versus idarubicin-12 for induction chemotherapy in acute myeloid leukemia: a retrospective analysis of the Mayo Clinic experience
por: Tefferi, Ayalew, et al.
Publicado: (2022)

Autophagy Inhibition Enhances Daunorubicin-Induced Apoptosis in K562 Cells
por: Han, Weidong, et al.
Publicado: (2011)

Dnmt3a Regulates T-cell Development and Suppresses T-ALL Transformation
por: Kramer, Ashley C., et al.
Publicado: (2017)

SPOCK1 Overexpression Confers a Poor Prognosis in Urothelial Carcinoma
por: Ma, Li-Jung, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_trrv65nj5fsfj1rht14hv0pg7i